TickerFactsScreenerDevelopers

CRISPR Therapeutics AG (CRSP) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$52.86M2017: -$70.09M2018: -$96.24M2019: $56.68M2020: -$238.37M2021: $538.97M2022: -$495.74M2023: -$260.38M2024: -$142.77M2025: -$345.01M-$345.01M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$345.01M-141.7%
2024-$142.77M+45.2%
2023-$260.38M+47.5%
2022-$495.74M-192.0%
2021$538.97M+326.1%
2020-$238.37M-520.6%
2019$56.68M+158.9%
2018-$96.24M-37.3%
2017-$70.09M-32.6%
2016-$52.86M—